I have finally got around to reading the UK Government response to the AMR Review, which includes some interesting details about aspirations to reduce Gram-negative BSIs (GNBSI) and antibacterial agent usage in human and animal health.
AMR Review
Review on AMR: final report
The final report from Jim O’Neill’s Review on AMR is published today. The report summarises the key findings of the reports published by The Review. The key interventions outlined in the report are:
- A global public awareness campaign
- Preventing the spread of infection
- Reducing unnecessary use of antibiotics, and controlling their environmental dissemination
- Improving surveillance of resistance and consumption
- Improving diagnostics
- Explore vaccines
- Improve remuneration for people working in ID (here here)
- Develop a global innovation fund for anti-infective drug development
- Incentivise anti-infective drug development
Not a great deal on infection prevention in the report – but this was covered in detail in a previous report. Some more excellent infographics, and an impressive Review. Well worth a read.
Review on AMR: progress to date
Like many others, I am keeping a close eye on the UK Government’s commissioned ‘Review on AMR’. The Review team have been tremendously productive over the last few years, already releasing detailed reports on:
Reflections on Infection Prevention and Control 